eMedicine Specialties > Neurology > Seizures and Epilepsy

Absence Seizures: Differential Diagnoses & Workup

Author: Scott Segan, MD, Director of SBH Stroke Center and Attending Neurologist, St Barnabas Hospital
Contributor Information and Disclosures

Updated: Apr 7, 2009

Differential Diagnoses

Complex Partial Seizures
Psychogenic Nonepileptic Seizures
Confusional States and Acute Memory Disorders
Reflex Epilepsy
Febrile Seizures
Shuddering Attacks
First Seizure: Pediatric Perspective
Status Epilepticus
Migraine Variants

Other Problems to Be Considered

Breath-holding spells
Nonconvulsive generalized status epilepticus

Workup

Laboratory Studies

  • When evaluating a child for staring spells, laboratory tests for metabolic abnormalities or toxic or drug ingestion (especially in older children) may be indicated. If a clear history of the episodic nature of the attacks is obtained, then the EEG can be diagnostic and laboratory tests may not be necessary.
  • When evaluating a child with a developmental delay, or if the EEG reveals atypical absences, then a full work-up for the underlying cause of a symptomatic generalized epilepsy is indicated.

Imaging Studies

  • Neuroimaging findings are normal in idiopathic epilepsies by definition1,34 and therefore neuroimaging is not indicated if the typical clinical pattern is present.
  • Neuroimaging is often ordered by primary care providers and the emergency department, especially if a child presents with a generalized tonic-clonic seizure, to rule out significant structural causes of seizures. A normal result helps support the diagnosis of idiopathic epilepsy. For cryptogenic and symptomatic generalized epilepsies, neuroimaging can help in diagnosing of any underlying structural abnormality.
  • If imaging is performed, MRI is preferred to CT scanning. MRI is more sensitive for certain anatomic abnormalities. A review of 134 MRIs in patients with idiopathic generalized epilepsies found nonspecific abnormalities in 24%.35

Other Tests

The only diagnostic test for absence seizures is the EEG.

  • Findings in typical absence seizures include the following:
    • Background activity is normal.
      • In syndromes with frequent absence seizures, such as childhood absence epilepsy, a routine awake recording is often pathognomonic.
      • Bursts of frontally predominant, generalized 3-Hz spike-and-wave complexes are seen during the seizures.4
      • In syndromes with less frequent absence seizures (juvenile absence epilepsy or juvenile myoclonic epilepsy), an awake recording may be normal; a sleep or sleep-deprived recording may be needed.
    • Typical absence seizures have generalized 3-Hz spike-and-wave complexes (see Media file 2).

      EEG of a typical absence seizure with 3-Hz spike-...

      EEG of a typical absence seizure with 3-Hz spike-and-wave discharges.

      EEG of a typical absence seizure with 3-Hz spike-...

      EEG of a typical absence seizure with 3-Hz spike-and-wave discharges.


      • The spike frequency is often faster at the onset, with a slight deceleration at the end.27 They can range from 2.5-6 Hz, with the faster frequencies seen in syndromes with older age of onset.
      • Bursts of generalized polyspikes and waves (multiple spike-and-slow-wave complexes) may also be seen31 , especially during sleep and in syndromes with older age of onset.
      • The onset and ending of these seizures are abrupt; no postictal EEG slowing is noted.
      • Hyperventilation often provokes these seizures and should be a routine part of all EEGs in children.
      • Photosensitivity may be present in idiopathic generalized epilepsies  and is more often seen in juvenile myoclonic epilepsy and childhood absence epilepsy than juvenile absence epilepsy.30
      • EEG video monitoring demonstrates that clinical seizure manifestations may lag behind the start of ictal EEG activity; bursts lasting less than 3 seconds are usually clinically silent. During the absence seizure, rhythmic eye blinks and mild clonic jerks may be present. As a seizure progresses, automatisms may be seen.33
      • Clinical and EEG features may vary considerably in different children.36
  • Findings in atypical absence seizures include the following:
    • Seizures are characterized by slow spike-and-wave paroxysms, classically 2.5 Hz (see Media file 3). The onset may be difficult to discern, and postictal EEG slowing may be noted.

      Slow spike-and-wave discharges (2.5 Hz). This is ...

      Slow spike-and-wave discharges (2.5 Hz). This is an interictal pattern in a child with seizures and developmental delay.

      Slow spike-and-wave discharges (2.5 Hz). This is ...

      Slow spike-and-wave discharges (2.5 Hz). This is an interictal pattern in a child with seizures and developmental delay.

    • Background activity is often abnormal, reflecting the diffuse or multifocal underlying encephalopathy of symptomatic generalized epilepsy.
    • Generalized polyspike-and-wave complexes also may be present, and focal features may be observed.
    • The clinical correlation of generalized spike-and-wave complexes with clinical seizures is not as clear-cut as in typical absence seizures. Generalized slow spikes and waves may be present as an interictal pattern, as in Lennox-Gastaut syndrome.
    • EEG-video monitoring can show a more varied alteration of consciousness than in typical absence seizures. If the patient has underlying mental retardation, discerning changes in mental status also may be more difficult in atypical absence.
    • Changes in postural tone, most noticeably head nods, are common.

Ambulatory EEG monitoring over 24 hours may be useful to quantitate the number of seizures per day and their most likely times of occurrence.

More on Absence Seizures

Overview: Absence Seizures
Differential Diagnoses & Workup: Absence Seizures
Treatment & Medication: Absence Seizures
Follow-up: Absence Seizures
Multimedia: Absence Seizures
References

References

  1. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. Aug 1981;22(4):489-501. [Medline].

  2. Blumenfeld H. From molecules to networks: cortical/subcortical interactions in the pathophysiology of idiopathic generalized epilepsy. Epilepsia. 2003;44 Suppl 2:7-15. [Medline].

  3. Temkin O. The Falling Sickness. Johns Hopkins Press: Baltimore, MD; 1971:250.

  4. Gibbs FA, Davis H, Lennox WG. The EEG in epilepsy and in conditions of impaired consciousness. Arch Neurol Psychiat. 1935;34:1134-48.

  5. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. Jul-Aug 1989;30(4):389-99. [Medline].

  6. Benbadis SR, Berkovic SF. Absence Seizures. In: Wyllie E, Gupta A and Lachhwani DK. The Treatment of Epilepsy. Principles and Practice. 4th ed. Philadelphia: Lippincott, Williams and Wilkins; 2006:305-315.

  7. Panayiotopoulos CP. Typical Absence Seizures. The International League Against Epilepsy. Available at http://www.ilae-epilepsy.org/Visitors/Centre/ctf/typical_absence.cfm. Accessed March 16, 2008.

  8. Dulac O. Atypical Absence. The International League Against Epilepsy. Available at http://www.ilae-epilepsy.org/Visitors/Centre/ctf/atypical_absence.cfm. Accessed March 16, 2008.

  9. Lennox WG, Lennox MA. Epilepsy and Related Disorders. Boston: Little, Brown; 1960:548-574.

  10. Rudolf G, Thérèse Bihoreau M, F Godfrey R, P Wilder S, D Cox R, Lathrop M, et al. Polygenic control of idiopathic generalized epilepsy phenotypes in the genetic absence rats from Strasbourg (GAERS). Epilepsia. Apr 2004;45(4):301-8. [Medline].

  11. Noebles JL, Fariello RG, Jobe PC, Lasley SN and Marescaux C. Genetic models of generalized epilepsy. In: Engel J Jr, Pedley TA. Epilepsy: A Comprehensive Textbook. Philadelphia, PA: Lippincott-Raven; 1997:2327-46.

  12. Benbadis SR. Practical management issues for idiopathic generalized epilepsies. Epilepsia. 2005;46 Suppl 9:125-32. [Medline].

  13. Greenberg DA, Delgado-Escueta AV, Widelitz H, Sparkes RS, Treiman L, Maldonado HM, et al. Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet. Sep 1988;31(1):185-92. [Medline].

  14. Liu AW, Delgado-Escueta AV, Gee MN, Serratosa JM, Zhang QW, Alonso ME, et al. Juvenile myoclonic epilepsy in chromosome 6p12-p11: locus heterogeneity and recombinations. Am J Med Genet. Jun 14 1996;63(3):438-46. [Medline].

  15. Bai D, Alonso ME, Medina MT, Bailey JN, Morita R, Cordova S, et al. Juvenile myoclonic epilepsy: linkage to chromosome 6p12 in Mexico families. Am J Med Genet. Dec 1 2002;113(3):268-74. [Medline].

  16. Stogmann E, Lichtner P, Baumgartner C, Bonelli S, Assem-Hilger E, Leutmezer F, et al. Idiopathic generalized epilepsy phenotypes associated with different EFHC1 mutations. Neurology. Dec 12 2006;67(11):2029-31. [Medline].

  17. Suzuki T, Delgado-Escueta AV, Aguan K, Alonso ME, Shi J, Hara Y, et al. Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat Genet. Aug 2004;36(8):842-9. [Medline].

  18. Annesi F, Gambardella A, Michelucci R, Bianchi A, Marini C, Canevini MP. Mutational analysis of EFHC1 gene in Italian families with juvenile myoclonic epilepsy. Epilepsia. Sep 2007;48(9):1686-90. [Medline].

  19. Pinto D, Louwaars S, Westland B, Volkers L, de Haan GJ, Trenité DG, et al. Heterogeneity at the JME 6p11-12 locus: absence of mutations in the EFHC1 gene in linked Dutch families. Epilepsia. Oct 2006;47(10):1743-6. [Medline].

  20. Fong GC, Shah PU, Gee MN, Serratosa JM, Castroviejo IP, Khan S, et al. Childhood absence epilepsy with tonic-clonic seizures and electroencephalogram 3-4-Hz spike and multispike-slow wave complexes: linkage to chromosome 8q24. Am J Hum Genet. Oct 1998;63(4):1117-29. [Medline].

  21. Wallace RH, Marini C, Petrou S, Harkin LA, Bowser DN, Panchal RG, et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet. May 2001;28(1):49-52. [Medline].

  22. Tanaka M, Olsen RW, Medina MT, Schwartz E, Alonso ME, Duron RM. Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy. Am J Hum Genet. Jun 2008;82(6):1249-61. [Medline].

  23. Jasper HH, Droogleever-Fortuyn J. Experimental studies on the functional anatomy of petit mal epilepsy. Assoc Res Nerv Ment Dis. 1947;26:272-98.

  24. Williams, D. A study of thalamic and cortical rhythms in petit mal. Brain. 1953;76:50-69.

  25. Gloor P, Quesney LF, Zumstein H. Pathophysiology of generalized penicillin epilepsy in the cat: the role of cortical and subcortical structures. II. Topical application of penicillin to the cerebral cortex and to subcortical structures. Electroencephalogr Clin Neurophysiol. Jul 1977;43(1):79-94. [Medline].

  26. Panayiotopoulos CP. Absence epilepsies. In: Engel J Jr, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia, PA: Lippincott-Raven; 1997:2327-46.

  27. Loiseau P. Childhood absence epilepsy. In: Roger J, Bureau M, Dravet, et al, eds. Epileptic Syndromes. London, England: John Libby; 1985: 106-20.

  28. Tassinari CA, Bureau M. Epilepsy with myoclonic absences. In: Roger J, Bureau M, Dravet, et al, eds. Epileptic Syndromes. London, England: John Libby; 1985:121-9.

  29. Beaumanoir A. Roger J, Bureau M, Dravet, et al, eds. Epileptic Syndromes. London, England: John Libby; 1985:11: 89-99.

  30. Wolf P. Juvenile absence epilepsy. In: Roger J, Bureau M, Dravet, et al, eds. Epileptic Syndromes. London, England: John Libby; 1985:242-6.

  31. Wolf P. Juvenile myoclonic epilepsy. In: Roger J, Bureau M, Dravet, et al, eds. Epileptic Syndromes. London, England: John Libby; 1985:247-58.

  32. Dreifuss FE. Classification of epileptic seizures. In: Engel J Jr, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia, PA: Lippincott-Raven;1997.

  33. Penry JK, Porter RJ, Dreifuss RE. Simultaneous recording of absence seizures with video tape and electroencephalography. A study of 374 seizures in 48 patients. Brain. Sep 1975;98(3):427-40. [Medline].

  34. Panayiotopoulos CP. Idiopathic generalized epilepsies: a review and modern approach. Epilepsia. 2005;46 Suppl 9:1-6. [Medline].

  35. Betting LE, Mory SB, Lopes-Cendes I, Li LM, Guerreiro MM, Guerreiro CA, et al. MRI reveals structural abnormalities in patients with idiopathic generalized epilepsy. Neurology. Sep 12 2006;67(5):848-52. [Medline].

  36. Sadleir LG, Farrell K, Smith S, Connolly MB, Scheffer IE. Electroclinical features of absence seizures in childhood absence epilepsy. Neurology. Aug 8 2006;67(3):413-8. [Medline].

  37. Browne TR, Penry JK, Proter RJ, Dreifuss FE. Responsiveness before, during, and after spike-wave paroxysms. Neurology. Jul 1974;24(7):659-65. [Medline].

  38. Lerman P. Seizures induced or aggravated by anticonvulsants. Epilepsia. Nov-Dec 1986;27(6):706-10. [Medline].

  39. Snead OC 3rd, Hosey LC. Exacerbation of seizures in children by carbamazepine. N Engl J Med. Oct 10 1985;313(15):916-21. [Medline].

  40. Liu L, Zheng T, Morris MJ, Wallengren C, Clarke AL, Reid CA, et al. The mechanism of carbamazepine aggravation of absence seizures. J Pharmacol Exp Ther. Nov 2006;319(2):790-8. [Medline].

  41. Vendrame M, Khurana DS, Cruz M, Melvin J, Valencia I, Legido A, et al. Aggravation of seizures and/or EEG features in children treated with oxcarbazepine monotherapy. Epilepsia. Nov 2007;48(11):2116-20. [Medline].

  42. Guerrini R, Belmonte A, Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia. 1998;39 Suppl 3:S2-10. [Medline].

  43. Skodda S, Kramer I, Spittler JF, Gehlen W. Non-convulsive status epilepticus in two patients receiving tiagabine add-on treatment. J Neurol. Feb 2001;248(2):109-12. [Medline].

  44. Perucca E. The management of refractory idiopathic epilepsies. Epilepsia. 2001;42 Suppl 3:31-5. [Medline].

  45. Hemingway C, Freeman JM, Pillas DJ, Pyzik PL. The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics. Oct 2001;108(4):898-905. [Medline].

  46. Edwards, N. The MCT Diet. epilepsy.com. Available at http://www.epilepsy.com/epilepsy/keto_news_august07. Accessed 3/15/09.

  47. Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics. Apr 2000;105(4):E46. [Medline].

  48. Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology. Oct 30 2007;69(18):1751-60. [Medline].

  49. Coppola G, Auricchio G, Federico R, Carotenuto M, Pascotto A. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Epilepsia. Sep 2004;45(9):1049-53. [Medline].

  50. Posner EB, Mohamed K, Marson AG. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev. 2005;(4):CD003032. [Medline].

  51. Wheeler MM, Winter ME. Valproic Acid. In: Winter ME. Basic Clinical Pharmacokinetics. 4. Philadelphia: Lippincott Williams & Wilkins; 2003:438/14.

  52. Tassinari CA, Dravet C, Roger J, Cano JP, Gastaut H. Tonic status epilepticus precipitated by intravenous benzodiazepine in five patients with Lennox-Gastaut syndrome. Epilepsia. Jul 1972;13(3):421-35. [Medline].

  53. Wirrell E, Camfield C, Camfield P, Dooley J. Prognostic significance of failure of the initial antiepileptic drug in children with absence epilepsy. Epilepsia. Jun 2001;42(6):760-3. [Medline].

  54. Delgado-Escueta AV, Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology. Mar 1984;34(3):285-94. [Medline].

Further Reading

Keywords

absence seizure, petit mal seizures, generalized seizures, idiopathic generalized epilepsy, symptomatic generalized epilepsy, seizure treatment, epilepsy treatment, idiopathic generalized epilepsies, childhood absence epilepsy, pyknolepsy, juvenile absence epilepsy, juvenile myoclonic epilepsy, impulsive petit mal seizures, typical absence seizures, symptomatic generalized epilepsies, nonpyknoleptic seizures, spanioleptic absence seizures

Contributor Information and Disclosures

Author

Scott Segan, MD, Director of SBH Stroke Center and Attending Neurologist, St Barnabas Hospital
Scott Segan, MD is a member of the following medical societies: American Academy of Neurology and American Epilepsy Society
Disclosure: UCB Pharma Honoraria Speaking and teaching

Medical Editor

Edward B Bromfield, MD, Associate Professor of Neurology, Faculty Member, Division of Sleep Medicine, Harvard Medical School; Chief, Division of EEG, Epilepsy and Sleep Neurology, Consulting Neurologist, Brigham and Women's Hospital
Edward B Bromfield, MD is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, American Epilepsy Society, American Neurological Association, and Massachusetts Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Jose E Cavazos, MD, PhD, FAAN, Associate Professor with Tenure, Departments of Neurology, Pharmacology, and Physiology, University of Texas Health Science Center at San Antonio; Co-Director, South Texas Comprehensive Epilepsy Center; Director of the Epilepsy Center, Audie L Murphy Veterans Affairs Medical Center
Jose E Cavazos, MD, PhD, FAAN is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, American Epilepsy Society, and Society for Neuroscience
Disclosure: Nothing to disclose.

CME Editor

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.